Nicotine binds to nicotinic acetylcholine receptors (nAChR), which can exist as many different subtypes. The α4β2 nAChR is the most prevalent subtype in the brain and possesses the most evidence linking it to nicotine seeking behavior.
Santos, Radleigh +10 more
core +1 more source
After three successive control applications of ACh, 10 µM asperparaline A was continuously bath-applied and then co-applied with 100 µM ACh. Asperparaline A blocked the ACh-response of
Saori Kataoka (353742) +4 more
core +1 more source
The habenula (Hb) is a diencephalic structure that receives substantial input from multiple parts of the limbic system, and communicates with the nucleus interpeduncularis (IPN) by means of the fasciculus retroflexus.
A. Zanardi +8 more
core +2 more sources
Structural differences determine the relative selectivity of nicotinic compounds for native α4β2^*-, α6β2^*-, α3β4^*- and α7-nicotine acetylcholine receptors [PDF]
Mammalian brain expresses multiple nicotinic acetylcholine receptor (nAChR) subtypes that differ in subunit composition, sites of expression and pharmacological and functional properties.
Breining, Scott R. +10 more
core
Pharmacological stress is required for the anti-alcohol effect of the α3β4* nAChR partial agonist AT-1001. [PDF]
Cippitelli A +4 more
europepmc +1 more source
Co-activation of Selective Nicotinic Acetylcholine Receptor Subtypes Is Required for Neuroprotection against Alzheimer's Disease. [PDF]
Lee R, Kim G, Black ER, Kim S.
europepmc +1 more source
Nicotinic Agonist Inhibits Cardiomyocyte Apoptosis in CVB3-Induced Myocarditis via α3β4-nAChR/PI3K/Akt-Dependent Survivin Upregulation. [PDF]
Li P +9 more
europepmc +1 more source
Toxicological and pharmacodynamic evaluation of Nixodine-S [(S)-6-Methylnicotine] relative to (S)-nicotine. [PDF]
Smith ML +5 more
europepmc +1 more source
An accessory orthosteric ligand binding site in the (α3)<sub>3</sub>(β4)<sub>2</sub> nicotinic acetylcholine receptor regulates channel activation. [PDF]
Kulkarni GC +3 more
europepmc +1 more source
Sustained abstinence in severe ketamine use disorder following ibogaine treatment case report. [PDF]
Pérez Rosal SR, Faber SC, Backmund M.
europepmc +1 more source

